Pyridazine derivatives of the formula (I) act as phosphodiesterase IV inhibitors and can be employed for the treatment of osteoporosis, tumours, cachexia, atherosclerosis, rheumatoid arthritis, multiple sclerosis, diabetes mellitus, inflammatory processes, allergies, asthma, autoimmune diseases, myocardial diseases and AIDS ##STR00001##

 
Web www.patentalert.com

< Inhibition of SARS-associated coronavirus (SCoV) infection and replication by RNA interference

< Lipid analogs for treating viral infections

> Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents

> Natural killer cell activating factor II

~ 00299